QURE Stock Outlook Rests on AMT-130, FDA Talks, and Cash Runway

uniQure N.V. QURE remains a catalyst-driven gene therapy stock, with AMT-130 shaping most of the investment debate. The program targets Huntington’s disease, an area where disease-modifying options remain absent. Recent FDA feedback, a targeted biologics license application submission in the third quarter of 2026 and …

Read more

Tesla Heads Into Its July 22 Earnings Down 22%, and One Firm Sees a 67% Plunge From Here. Who's Right?

Key Points Tesla delivered 480,126 vehicles in the second quarter, up 25% year over year. Wells Fargo raised its price target to $130 last week, a level implying a 67% drop from today’s price. The stock trades at about 360 times earnings heading into Wednesday’s …

Read more

Alphabet vs. Apple: Which Warren Buffett Favorite Is the Better Stock to Buy Today?

Key Points Apple has one of the best business models on the planet, but its valuation currently reflects that. Alphabet is the much cheaper stock and is well positioned as the most complete AI company. 10 stocks we like better than Apple › Throughout his …

Read more

Which "Magnificent Seven" Stock Has the Best Risk/Reward Right Now?

Key Points The giant “Magnificent Seven” stocks have had subpar performance so far in 2026. Some, like Tesla, are very risky stocks with very high reward potential. Others, like Amazon, have lower risk but also lower potential rewards. 10 stocks we like better than Nvidia …

Read more

What Do SpaceX, AMD, and Palantir Have in Common?

Key Points Space Exploration Technologies (NASDAQ: SPCX), AMD (NASDAQ: AMD), and Palantir Technologies (NASDAQ: PLTR) may seem like an odd grouping of companies. But I have a good reason to consider them together: They’re all incredibly overvalued. While that may sound like a shocking statement, …

Read more

The Chip Index Just Fell Into a Bear Market. Apple Is Sitting Near an All-Time High Anyway.

Key Points The PHLX Semiconductor Index closed in a bear market on Friday, more than 20% below its June peak. Apple set a record intraday high the same day and passed Nvidia to become the world’s most valuable company. Apple spent $12.7 billion on capital …

Read more

uniQure Trends to Watch as Gene Therapy Bets Shift Beyond Hemgenix

uniQure N.V. QURE now represents more than a single-program gene therapy story. Its profile is being reshaped by faster regulatory pathways, a narrower operating model and clinical work in rare neurological diseases. Those trends matter because investors are watching whether uniQure can build the next …

Read more

Crypto Market Update: Crypto.com Hits US$20 Billion Valuation

Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrencymarket news Here’s a quick recap of the crypto landscape for Friday (July 17) as of 10:00 p.m. UTC. Bitcoin price update Bitcoin (BTC) was priced at US$64,129.58, up by …

Read more

Warren Buffett Is Disposing of His Berkshire Shares. Here's How.

Key Points Warren Buffett has a new plan to dispose of all his Berkshire Hathaway (NYSE: BRKA) (NYSE: BRKB) shares. The legendary investor and former CEO of Berkshire owns about 188,000 Class A shares of the conglomerate he built over five decades, as well as …

Read more

Friday's ETF with Unusual Volume: FFLG

The Fidelity Fundamental Large Cap Growth ETF is seeing unusually high volume in afternoon trading Friday, with over 2.0 million shares traded versus three month average volume of about 89,000. Shares of FFLG were off about 1.2% on the day. Components of that ETF with …

Read more